-The Hindu The much-awaited Drug (Prices Control) Order 2013 has disappointed millions of patients, as it lacks a fair formula to fix the price ceiling and leaves important drug classes out of regulation. The result: High out-of-pocket spending on medicines will continue As far as intentions go, the Drug (Prices Control) Order 2013 is aimed at making critical drugs affordable and available to the public, while preserving a rationale for manufacture by...
More »SEARCH RESULT
Total Matching Records found : 528
Northeast HIV tests hit by reagent hurdle-GS Mudur
-The Telegraph New Delhi: Patients infected with the human immuno-deficiency virus (HIV) in the northeastern states have been unable to undergo a key test required to start anti-HIV drugs for several weeks because of delays in procurement by government agencies, patient interest groups said today. The Indian Drug Users Forum said several government HIV-treatment centres across Manipur, Meghalaya, Nagaland and Tripura are facing a "complete stock-out" of biochemical reagents that measure levels...
More »Food security bill has a sting in the tail for Maharashtra-Yogesh Pawar
-DNA The Centre may have used the ordinance mode to push through with the Food Security Bill in the hope that this will bring political dividends but many of its stipulations will lead to serious challenges, even in a Cong-NCP ruled state like Maharashtra. On one hand, the total food grain availability in the state will go up from 3.95 lakh tonnes to 4.25 lakh tonnes, but only 75% from existing...
More »Millennium Development Goals are within reach, but stronger efforts needed –UN report
-The United Nations Thirteen years after the world set the Millennium Development Goals (MDGs), countries have made big strides to meet the eight anti-poverty targets by their 2015 deadline, says a United Nations report released today, which stresses that the unmet goals are still within reach, but nations need to step up their efforts to achieve them. "In more than a decade of experience in working towards the MDGs, we have learned...
More »Ranbaxy drugs fine, say WHO and UK regulator -Rema Nagarajan
-The Times of India NEW DELHI: In yet another twist to the Ranbaxy scandal, the drug regulatory authority of the UK government has issued a statement clarifying that they have found no evidence of any Ranbaxy product in the UK market having been "of unacceptable quality". Last month, WHO had issued a similar statement. It had said that there was no evidence of any of the Ranbaxy products being of unacceptable...
More »
